Table 1 Baseline Characteristics of the Study Population

Age, yrs

61.1 ± 11.0

66.1 ± 11.2

0.16

Male, n (%)

17 (85)

13 (65)

0.14

Body mass index, kg/m²

27.4 ± 3.6

26.3 ± 4.3

0.37

Current Smoker, n (%)

7 (35)

4 (20)

0.24

Hypertension, n (%)

13 (65)

17 (85)

0.14

Dyslipidemia, n (%)

15 (75)

11 (55)

0.19

Diabetes, n (%)

8 (40)

7 (35)

0.74

SDB (ODI 3%), n (%)

6 (30)

6 (30)

1.00

Previous MI, n (%)

0 (0)

0 (0)

1.0

Previous AP, n (%)

2 (10)

1 (5)

0.55

Previous PCI, n (%)

2 (10)

1 (5)

0.55

Previous CABG, n (%)

0 (0)

0 (0)

1.0

Previous stroke, n (%)

1 (5)

1 (5)

1.0

PAD, n (%)

0 (0)

0 (0)

1.0

Family History of CAD, n (%)

8 (40)

6 (30)

0.51

LVEF, %

69.9 ± 6.3

69.4 ± 6.2

0.74

eGFR, ml/min/1.73m²

65.8 ± 18.5

68.2 ± 17.2

0.68

Platelet counts, ×10³/μL

21.0 ± 5.9

20.0 ± 4.2

0.54

 Aspirin, n (%)

20 (100)

20 (100)

1.00

 PPI, n (%)

15 (75)

11 (55)

0.19

 OAD, n (%)

8 (40)

4 (20)

0.17

 Insulin therapy, n (%)

0 (0)

1 (5)

0.31

 Statins, n (%)

15 (75)

11 (55)

0.19

 Nitrates, n (%)

6 (30)

3 (15)

0.26

 CCB, n (%)

9 (45)

10 (50)

0.75

 ACEIs/ ARBs, n (%)

11 (55)

11 (55)

1.00

 Beta blockers, n (%)

15 (75)

12 (60)

0.31